Nomura Asset Management CO LTD Day One Biopharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$12.72 - $16.03 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$12.03 - $17.69 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$13.56 - $17.46 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$9.68 - $15.37 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$11.22 - $14.86 $0 - $0
0 New
0 $0

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $948M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email